Do you know 7 out of 100 patients acquire healthcare-associated infections (HAIs) in developed countries? Several studies reveal that 5–15% of patients in high-income countries acquire HAIs, which affect 9–37% of those admitted in intensive care units (ICUs) and can turn out to be fatal.

The Agency for Health care Research and Quality has reported that HAIs are the most common complications in hospitals and one of the leading causes of deaths in the US.

This blog reflects on the prevalence of HAIs and types of infections that can lead to fatal diseases among patients.

Urinary Tract Infections (UTIs): These infections constitute a major share of the HAI diagnostics market. UTIs are spread majorly due to urinary catheter (a latex type of tube inserted to drain and clean urine from a patient’s bladder). Over 15% of hospitalized patients receive urinary catheters at hospitals and disease is caused due to prolonged usage of the urinary catheter.

Surgical Site Infections (SSIs): Surgical site infections are common following major gastrointestinal (GI) surgeries, which affect between 20% and 40% of patients. SSIs cause pain and discomfort and also put patients at a high risk of secondary infectious complications. SSIs account for one-third of post-operative deaths. Such infections are expected to grow at a steady pace due to the poor quality of infrastructure in hospitals and an increase in patients requiring such surgeries.

Hospital-acquired Pneumonia (HAP): The high prevalence of HAP and related deaths, which are increasing at an alarming rate, is expected to grow at a faster rate. HAP commonly occurred in patients that undergo mechanical ventilation in hospitals. Such type of pneumonia is estimated to occur at a rate of 5–10 cases per 1,000 patients admitted in hospitals. HAP is the most common hospital-acquired infection causing death globally.

Know the latest trends and drivers of HAI diagnostics market – Read now!

Geographical View

North America is the leading contributor in terms of value toward the HAI diagnostics market. The US holds the highest market revenue due to better healthcare accessibility and insurance coverage.

In Europe, countries such as Germany, France, the UK, Spain, Italy, and Denmark carry a large burden of HAIs. The contributing factor for growth is the increasing incidence rate of HAIs. The European Centre for Disease Control and Prevention (ECDC) concluded that there are millions of cases of HAIs occur alone in Europe.

Request for your free sample now!

Prominent Vendors in HAI diagnostics market:

  • Danaher
  • Becton Dickinson
  • Abbott
  • Hoffmann-La Roche
  • BioMérieux
  • QIAGEN
  • Meridian Bioscience

Find interesting insights on related reports

You may reach us at

enquiry@arizton.com